The 3D-printed blood vessels are customizable per the particular patient and have potential to replace damaged blood vessels in patients with heart disease.
The vessels are created by a printing nozzle that forms tubes with distinct layers filled with ink made from human cells injected into a jelly-like substance. After the printing, the cells multiply until fully formed.
The research team hopes the printed blood vessels can be used to test the safety and efficacy of drugs.
“We’re [interested in] developing technology that can allow us to generate in vitro models of human vessels,” Yu Shrike Zhang, PhD, an associate bioengineer in Brigham’s department of medicine, told STAT.
More articles on clinical leadership and infection control:
Hospital privacy curtains are breeding MRSA, study finds
Mass General physician: Pollution is healthcare’s hidden harm
US News medical school rankings have little effect on patient outcomes, study finds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.